- Home
- AUPH vs ERII Comparison
AUPH vs ERII Comparison
Compare AUPH & ERII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | ERII |
|---|---|---|
| Founded | 1993 | 1992 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 740.3M |
| IPO Year | 1999 | 2008 |
Fundamental Metrics
Financial Performance| Metric | AUPH | ERII |
|---|---|---|
| Price | $15.87 | $13.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $17.25 | $16.50 |
| AVG Volume (30 Days) | ★ 1.2M | 433.6K |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.56 |
| EPS | ★ 0.55 | 0.36 |
| Revenue | ★ $265,808,000.00 | $135,191,000.00 |
| Revenue This Year | $21.76 | $5.93 |
| Revenue Next Year | $16.45 | $8.97 |
| P/E Ratio | ★ $29.54 | $38.92 |
| Revenue Growth | ★ 20.62 | 0.10 |
| 52 Week Low | $6.55 | $10.86 |
| 52 Week High | $16.54 | $18.32 |
Technical Indicators
Market Signals| Indicator | AUPH | ERII |
|---|---|---|
| Relative Strength Index (RSI) | 54.19 | 39.87 |
| Support Level | $16.00 | $13.70 |
| Resistance Level | $16.54 | $14.11 |
| Average True Range (ATR) | 0.40 | 0.34 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 50.72 | 10.23 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About ERII Energy Recovery Inc.
Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.